Literature DB >> 10751414

Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform.

H Liu1, M Sugiura, V E Nava, L C Edsall, K Kono, S Poulton, S Milstien, T Kohama, S Spiegel.   

Abstract

Sphingosine-1-phosphate (SPP) has diverse biological functions acting inside cells as a second messenger to regulate proliferation and survival, and extracellularly, as a ligand for G protein-coupled receptors of the endothelial differentiation gene-1 subfamily. Based on sequence homology to murine and human sphingosine kinase-1 (SPHK1), which we recently cloned (Kohama, T., Oliver, A., Edsall, L. , Nagiec, M. M., Dickson, R., and Spiegel, S. (1998) J. Biol. Chem. 273, 23722-23728), we have now cloned a second type of mouse and human sphingosine kinase (mSPHK2 and hSPHK2). mSPHK2 and hSPHK2 encode proteins of 617 and 618 amino acids, respectively, both much larger than SPHK1, and though diverging considerably, both contain the conserved domains found in all SPHK1s. Northern blot analysis revealed that SPHK2 mRNA expression had a strikingly different tissue distribution from that of SPHK1 and appeared later in embryonic development. Expression of SPHK2 in HEK 293 cells resulted in elevated SPP levels. d-erythro-dihydrosphingosine was a better substrate than d-erythro-sphingosine for SPHK2. Surprisingly, d, l-threo-dihydrosphingosine was also phosphorylated by SPHK2. In contrast to the inhibitory effects on SPHK1, high salt concentrations markedly stimulated SPHK2. Triton X-100 inhibited SPHK2 and stimulated SPHK1, whereas phosphatidylserine stimulated both type 1 and type 2 SPHK. Thus, SPHK2 is another member of a growing class of sphingolipid kinases that may have novel functions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751414     DOI: 10.1074/jbc.M002759200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  228 in total

1.  Lmo2 (LIM-Domain-Only 2) Modulates Sphk1 (Sphingosine Kinase) and Promotes Endothelial Cell Migration.

Authors:  Gianfranco Matrone; Shu Meng; Qilin Gu; Jie Lv; Longhou Fang; Kaifu Chen; John P Cooke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-08-03       Impact factor: 8.311

Review 2.  The therapeutic potential of modulating the ceramide/sphingomyelin pathway.

Authors:  Richard Kolesnick
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

3.  Sphingosine 1-phosphate, a diffusible calcium influx factor mediating store-operated calcium entry.

Authors:  Kiyoshi Itagaki; Carl J Hauser
Journal:  J Biol Chem       Date:  2003-05-13       Impact factor: 5.157

4.  Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors.

Authors:  Mithun R Raje; Kenneth Knott; Yugesh Kharel; Philippe Bissel; Kevin R Lynch; Webster L Santos
Journal:  Bioorg Med Chem       Date:  2011-11-15       Impact factor: 3.641

Review 5.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 6.  Insights into the pharmacological relevance of lysophospholipid receptors.

Authors:  Tetsuji Mutoh; Richard Rivera; Jerold Chun
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

7.  Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer Progression.

Authors:  Randy S Schrecengost; Staci N Keller; Matthew J Schiewer; Karen E Knudsen; Charles D Smith
Journal:  Mol Cancer Res       Date:  2015-08-13       Impact factor: 5.852

8.  Development of SKI-349, a dual-targeted inhibitor of sphingosine kinase and microtubule polymerization.

Authors:  Jeremy A Hengst; Shailaja Hegde; Robert F Paulson; Jong K Yun
Journal:  Bioorg Med Chem Lett       Date:  2020-07-28       Impact factor: 2.823

9.  Dynamic regulation of sphingosine-1-phosphate homeostasis during development of mouse metanephric kidney.

Authors:  R Jason Kirby; Ying Jin; Jian Fu; Jimena Cubillos; Debi Swertfeger; Lois J Arend
Journal:  Am J Physiol Renal Physiol       Date:  2008-12-10

10.  Increased SPHK1 expression is associated with poor prognosis in bladder cancer.

Authors:  Xiao-Dong Meng; Zhan-Song Zhou; Jian-Hong Qiu; Wen-Hao Shen; Qu Wu; Jun Xiao
Journal:  Tumour Biol       Date:  2013-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.